VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
131 hedge funds and large institutions have $191M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 18 closing their positions.
Holders
131
Holders Change
-3
Holders Change %
-2.24%
% of All Funds
2.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
46
Reduced
35
Closed
18
Calls
$1M
Puts
$383K
Net Calls
+$620K
Net Calls Change
+$627K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$26.9M |
| 2 |
2
Morgan Stanley
New York
|
$1.63M |
| 3 |
FWM
3
Frontier Wealth Management
Kansas City,
Missouri
|
$951K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$1.34M |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$1.71M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$948K |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$688K |
| 3 |
3
Citigroup
New York
|
$293K |
| 4 |
4
Group One Trading
Chicago,
Illinois
|
$164K |
| 5 |
5
Goldman Sachs
New York
|
$1.67M |
